Radiat Oncol 2018 Mar 20
A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma.
Related Questions
What factors would you consider? What if this meant treatment of the full kidney? If treatment is recommended, would you utilize an SBRT approach...
New answer by Radiation Oncologist at University of Toronto (December 7, 2018)
If patient is oligometastatic, I think renal SABR is a reasonable option, and there does not appear to be a location restriction (i.e. central close to hilum vs. more peripher...